Advisor Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$49K Hold
7,788
﹤0.01% 3433
2019
Q3
$33K Hold
7,788
﹤0.01% 3684
2019
Q2
$36K Sell
7,788
-2,486
-24% -$11.6K ﹤0.01% 3594
2019
Q1
$54K Sell
10,274
-669
-6% -$3.06K ﹤0.01% 3337
2018
Q4
$40K Buy
10,943
+3,943
+56% +$13.8K ﹤0.01% 3352
2018
Q3
$20K Sell
7,000
-410
-6% -$1.15K ﹤0.01% 3918
2018
Q2
$22K Buy
7,410
+410
+6% +$972 ﹤0.01% 3672
2018
Q1
$16K Sell
7,000
-23,543
-77% -$55.1K ﹤0.01% 3839
2017
Q4
$90K Sell
30,543
-12,186
-29% -$33.7K ﹤0.01% 2656
2017
Q3
$126K Sell
42,729
-2,337
-5% -$7.12K ﹤0.01% 2219
2017
Q2
$126K Buy
45,066
+13,341
+42% +$28.2K ﹤0.01% 2122
2017
Q1
$60K Buy
31,725
+24,025
+312% +$46.3K ﹤0.01% 2574
2016
Q4
$13K Sell
7,700
-950
-11% -$1.94K ﹤0.01% 3514
2016
Q3
$23K Buy
8,650
+1,650
+24% +$4.19K ﹤0.01% 3077
2016
Q2
$16K Buy
+7,000
New +$19.3K ﹤0.01% 3234

Other funds holding BDSI

Advisor Group's BDSI Position: Q4 2019 in Review

Advisor Group held its BioDelivery Sciences International, Inc. (BDSI) position steady in Q4 2019 at 7,788 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #3433.

Advisor Group first reported a position in BDSI in Q2 2016 and has held it in 15 quarters since. The position peaked at $126K in Q3 2017. 157 funds tracked by Wall St. Rank hold BDSI as of Q4 2019.

  • Advisor Group held 7,788 shares of BioDelivery Sciences International, Inc. worth $49K as of Q4 2019.
  • Advisor Group left its BioDelivery Sciences International, Inc. share count unchanged in Q4 2019.
  • BioDelivery Sciences International, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3433 holding.
  • Advisor Group first reported a position in BioDelivery Sciences International, Inc. in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's BioDelivery Sciences International, Inc. position peaked at $126K in Q3 2017.
  • 157 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.